🇺🇸 FDA
Patent

US 9260511

Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB

granted A61KA61K39/40A61K45/06

Quick answer

US patent 9260511 (Antibodies or fragments thereof directed against a Staphylococcus aureus epitope of IsaA or IsaB) held by Julius-Maximilians-Universitat Wurzburg expires Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Julius-Maximilians-Universitat Wurzburg
Grant date
Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K39/40, A61K45/06, A61P, A61P15/14